C12orf4 Antibodies

Santa Cruz Biotechnology features a diverse variety of C12orf4 monoclonal antibodies for research applications. C12orf4 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C12orf4, also known as the chromosome 12 open reading frame 4, plays a significant role in cellular processes, including cell proliferation and apoptosis. C12orf4 expression has been linked to various biological functions, making it an important target for understanding disease mechanisms and potential therapeutic interventions. The study of C12orf4 is crucial for advancing knowledge in cancer research and other pathologies. Researchers worldwide utilize C12orf4 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Understanding C12orf4's role in disease progression helps identify new therapeutic targets and biomarkers. Santa Cruz Biotechnology monoclonal antibodies for C12orf4 enable researchers to make meaningful contributions to scientific discovery and medical advancement.